What do we really know about benign prostatic hyperplasia and lower urinary tract symptoms in adult men? Matthias OelkeMartin C. Michel Editorial Open access 26 February 2011 Pages: 141 - 142
Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample Richard BergesAndrea GsurStephan Madersbacher Topic Paper Open access 17 November 2009 Pages: 143 - 148
The muscarinic receptor antagonist propiverine exhibits α1-adrenoceptor antagonism in human prostate and porcine trigonum Melinda WuestLambertus P. WitteUrsula Ravens Topic Paper Open access 19 February 2011 Pages: 149 - 155
Beta-arrestin-2 is expressed in human prostate smooth muscle and a binding partner of α1A-adrenoceptors Martin HennenbergBoris SchlenkerChristian Gratzke Original Article 22 January 2011 Pages: 157 - 163
Correlation of in vivo bladder blood flow measurements with tissue hypoxia Wei-Yu LinAnita MannikarottuRobert M. Levin Original Article 04 February 2009 Pages: 165 - 170
Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older Richard BergesMatthias Oelke Topic Paper 08 January 2011 Pages: 171 - 178
Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men Sean A. MartinMatthew T. HarenMembers of the Florey Adelaide Male Ageing Study Original Article 21 October 2010 Pages: 179 - 184
Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study Young-Suk LeeKyu-Sung LeeMyung-Soo Choo Original Article 08 November 2009 Pages: 185 - 190
The role of invasive and non-invasive urodynamics in male voiding lower urinary tract symptoms Brian A. ParsonsElizabeth BrightMarcus J. Drake Topic Paper 15 November 2009 Pages: 191 - 197
The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia Charalampos MamoulakisThomas R. W. HerrmannMatthias Oelke Topic Paper Open access 16 November 2010 Pages: 199 - 204
The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate Charalampos MamoulakisIoannis EfthimiouFrank Sofras Topic Paper Open access 12 May 2010 Pages: 205 - 210
Impact of oral anticoagulation on morbidity of transurethral resection of the prostate Aurélien DescazeaudGregoire RobertAlexandre de la Taille Original Article 25 June 2010 Pages: 211 - 216
Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study Matthias OelkeSandra MurgasMartin C. Michel Topic Paper Open access 16 February 2011 Pages: 217 - 223
Clinical efficacy of a loading dose of naftopidil for patients with benign prostate hyperplasia Yasuhito FunahashiRyohei HattoriMomokazu Gotoh Original Article 23 March 2010 Pages: 225 - 231
α1-Adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume Osamu YokoyamaYoshitaka AokiAkihiko Okuyama Original Article 13 April 2010 Pages: 233 - 238
Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways J. N. CornuB. MerletF. Haab Original Article 14 July 2010 Pages: 239 - 242
PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study Gianna PacePaola PalumboCarlo Vicentini Original Article 23 February 2010 Pages: 243 - 248
Treatment of moderate to severe female stress urinary incontinence with the adjustable continence therapy (ACT) device after failed surgical repair Sherif R. AboseifPejvak SassaniSuzette E. Sutherland Original Article 20 October 2010 Pages: 249 - 253